- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
ZN.3: 4 residues within 4Å:- Chain A: H.65, H.69, C.99, C.102
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.65, A:H.69, A:C.99, A:C.102
ZN.31: 4 residues within 4Å:- Chain E: H.65, H.69, C.99, C.102
4 PLIP interactions:4 interactions with chain E- Metal complexes: E:H.65, E:H.69, E:C.99, E:C.102
- 2 x R7N: 4-azanyl-~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[2-(2-morpholin-4-ylethylsulfonyl)ethyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide(Non-covalent)
R7N.4: 18 residues within 4Å:- Chain A: D.131, D.188, Q.189, G.190, P.214, Y.215, P.217, Q.218, E.224, R.332, R.365
- Chain C: G.4
- Chain D: C.16, A.17
- Ligands: MG.1, MG.2, SO4.15, SO4.16
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:P.217, A:P.217
- Hydrogen bonds: A:R.365, A:R.365
- Water bridges: A:D.131, A:Y.132, A:E.224, A:E.224, A:N.227
R7N.32: 18 residues within 4Å:- Chain E: D.131, D.188, Q.189, G.190, P.214, Y.215, P.217, Q.218, E.224, R.332, R.365
- Chain G: G.4
- Chain H: C.16, A.17
- Ligands: MG.29, MG.30, SO4.43, SO4.44
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:P.217, E:P.217
- Hydrogen bonds: E:R.365, E:R.365
- Water bridges: E:Y.132, E:N.227
- 34 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 6 residues within 4Å:- Chain A: S.335, L.336, R.339
- Chain E: K.231
- Chain H: C.16
- Ligands: GOL.20
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: P.118, D.119
- Chain C: T.3
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: P.138, S.139, Q.140, K.244
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: T.161, K.162, A.163, A.168
Ligand excluded by PLIPSO4.9: 5 residues within 4Å:- Chain A: R.117, Y.306, P.308
- Chain C: C.6
- Ligands: GOL.27
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: H.341, K.342, H.360
Ligand excluded by PLIPSO4.11: 5 residues within 4Å:- Chain A: L.76, A.80, W.84, M.88
- Chain H: T.8
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain A: S.309, T.310
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain A: Y.306, H.307, P.308, S.309
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain A: K.342, D.359, H.360, G.362
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain A: Y.215, R.332
- Ligands: R7N.4
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain A: G.190, A.191
- Chain D: A.17
- Ligands: R7N.4
Ligand excluded by PLIPSO4.17: 1 residues within 4Å:- Chain A: H.208
Ligand excluded by PLIPSO4.18: 7 residues within 4Å:- Chain A: Y.266, Q.270, G.274, I.275, N.283, T.286, I.301
Ligand excluded by PLIPSO4.24: 1 residues within 4Å:- Chain B: T.213
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain B: K.222, R.225, S.261, P.262, V.263
Ligand excluded by PLIPSO4.28: 2 residues within 4Å:- Chain D: G.4, A.5
Ligand excluded by PLIPSO4.33: 6 residues within 4Å:- Chain A: K.231
- Chain D: C.16
- Chain E: S.335, L.336, R.339
- Ligands: GOL.48
Ligand excluded by PLIPSO4.34: 3 residues within 4Å:- Chain E: P.118, D.119
- Chain G: T.3
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain E: P.138, S.139, Q.140, K.244
Ligand excluded by PLIPSO4.36: 4 residues within 4Å:- Chain E: T.161, K.162, A.163, A.168
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain E: R.117, Y.306, P.308
- Chain G: C.6
- Ligands: GOL.55
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain E: H.341, K.342, H.360
Ligand excluded by PLIPSO4.39: 5 residues within 4Å:- Chain D: T.8
- Chain E: L.76, A.80, W.84, M.88
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain E: S.309, T.310
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain E: Y.306, H.307, P.308, S.309
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain E: K.342, D.359, H.360, G.362
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain E: Y.215, R.332
- Ligands: R7N.32
Ligand excluded by PLIPSO4.44: 4 residues within 4Å:- Chain E: G.190, A.191
- Chain H: A.17
- Ligands: R7N.32
Ligand excluded by PLIPSO4.45: 1 residues within 4Å:- Chain E: H.208
Ligand excluded by PLIPSO4.46: 7 residues within 4Å:- Chain E: Y.266, Q.270, G.274, I.275, N.283, T.286, I.301
Ligand excluded by PLIPSO4.52: 1 residues within 4Å:- Chain F: T.213
Ligand excluded by PLIPSO4.53: 5 residues within 4Å:- Chain F: K.222, R.225, S.261, P.262, V.263
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain H: G.4, A.5
Ligand excluded by PLIP- 12 x GOL: GLYCEROL(Non-functional Binders)
GOL.19: 5 residues within 4Å:- Chain A: Q.63, L.82, Y.83
- Chain E: P.280, F.281
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain E- Hydrogen bonds: A:Q.63, E:F.281
GOL.20: 6 residues within 4Å:- Chain A: R.339
- Chain E: S.228, T.235
- Chain H: A.15, C.16
- Ligands: SO4.5
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:S.228
- Water bridges: A:T.105
GOL.21: 3 residues within 4Å:- Chain A: S.165, T.166, S.167
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:T.166, A:T.166, A:S.167
GOL.22: 7 residues within 4Å:- Chain A: L.295, Q.299
- Chain B: Y.266, Q.270, G.274, I.275, D.276
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.276
GOL.26: 2 residues within 4Å:- Chain B: G.221, R.225
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.221, B:R.225, B:R.225
GOL.27: 7 residues within 4Å:- Chain A: V.263
- Chain C: C.6, A.7, T.8
- Chain D: C.11, A.12
- Ligands: SO4.9
1 PLIP interactions:1 interactions with chain A- Water bridges: A:V.263
GOL.47: 5 residues within 4Å:- Chain A: P.280, F.281
- Chain E: Q.63, L.82, Y.83
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain E- Hydrogen bonds: A:F.281, E:Q.63, E:Y.83
GOL.48: 6 residues within 4Å:- Chain A: S.228, T.235
- Chain D: A.15, C.16
- Chain E: R.339
- Ligands: SO4.33
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Water bridges: E:T.105
- Hydrogen bonds: A:S.228, A:T.235
GOL.49: 3 residues within 4Å:- Chain E: S.165, T.166, S.167
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:T.166, E:S.167
GOL.50: 7 residues within 4Å:- Chain E: L.295, Q.299
- Chain F: Y.266, Q.270, G.274, I.275, D.276
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:D.276, F:D.276
GOL.54: 2 residues within 4Å:- Chain F: G.221, R.225
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:G.221, F:R.225, F:R.225
GOL.55: 7 residues within 4Å:- Chain E: V.263
- Chain G: C.6, A.7, T.8
- Chain H: C.11, A.12
- Ligands: SO4.37
1 PLIP interactions:1 interactions with chain E- Water bridges: E:V.263
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, S.J. et al., HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants. Acs Infect Dis. (2021)
- Release Date
- 2021-03-24
- Peptides
- Integrase: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x R7N: 4-azanyl-~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[2-(2-morpholin-4-ylethylsulfonyl)ethyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide(Non-covalent)
- 34 x SO4: SULFATE ION(Non-functional Binders)
- 12 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Smith, S.J. et al., HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants. Acs Infect Dis. (2021)
- Release Date
- 2021-03-24
- Peptides
- Integrase: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B